DK1680128T3 - Myo-inositolhexaphosphat til topisk anvendelse - Google Patents
Myo-inositolhexaphosphat til topisk anvendelseInfo
- Publication number
- DK1680128T3 DK1680128T3 DK04798764T DK04798764T DK1680128T3 DK 1680128 T3 DK1680128 T3 DK 1680128T3 DK 04798764 T DK04798764 T DK 04798764T DK 04798764 T DK04798764 T DK 04798764T DK 1680128 T3 DK1680128 T3 DK 1680128T3
- Authority
- DK
- Denmark
- Prior art keywords
- myo
- inositol hexaphosphate
- topical use
- development
- treatment
- Prior art date
Links
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Diphosphoinositol tetrakisphosphate Chemical compound OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 title abstract 4
- 230000000699 topical effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 210000004872 soft tissue Anatomy 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cardiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200302600A ES2232302B1 (es) | 2003-11-07 | 2003-11-07 | Myo-inositol hexafosfato para uso topico. |
| PCT/IB2004/003588 WO2005044278A1 (en) | 2003-11-07 | 2004-11-03 | Myo-inositol hexaphosphate for topical use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1680128T3 true DK1680128T3 (da) | 2007-06-11 |
Family
ID=34566008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04798764T DK1680128T3 (da) | 2003-11-07 | 2004-11-03 | Myo-inositolhexaphosphat til topisk anvendelse |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20070066574A1 (da) |
| EP (1) | EP1680128B1 (da) |
| JP (1) | JP4786543B2 (da) |
| AT (1) | ATE353655T1 (da) |
| BR (1) | BRPI0415713A (da) |
| CA (1) | CA2544963C (da) |
| CY (1) | CY1106574T1 (da) |
| DE (1) | DE602004004817T2 (da) |
| DK (1) | DK1680128T3 (da) |
| ES (2) | ES2232302B1 (da) |
| MX (1) | MXPA06005043A (da) |
| PL (1) | PL1680128T3 (da) |
| PT (1) | PT1680128E (da) |
| SI (1) | SI1680128T1 (da) |
| WO (1) | WO2005044278A1 (da) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2828206B1 (fr) * | 2001-08-03 | 2004-09-24 | Centre Nat Rech Scient | Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire |
| EP1503768B1 (en) * | 2002-04-29 | 2015-10-28 | NormOxys, Inc. | Inositol pyrophosphates, and use thereof |
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| US20060258626A1 (en) * | 2004-07-06 | 2006-11-16 | Claude Nicolau | Use of inositol-tripyrophosphate in treating tumors and diseases |
| US20060106000A1 (en) * | 2004-07-06 | 2006-05-18 | Claude Nicolau | Use of inositol-tripyrophosphate in treating tumors and diseases |
| US7745423B2 (en) * | 2004-07-06 | 2010-06-29 | NormOxys, Inc | Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin |
| CA2601641A1 (en) * | 2005-03-18 | 2006-09-28 | Oxyplus, Inc. | Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin |
| ES2272191B1 (es) * | 2005-10-14 | 2008-04-01 | Universitat De Les Illes Balears | Utilizacion del fitato para el tratamiento del agua. |
| ES2280136B1 (es) | 2006-02-17 | 2008-08-16 | Universitat De Les Illes Balears | Asociacion a dosis fija de fitato y zinc. |
| ES2288126B2 (es) * | 2006-06-01 | 2009-07-06 | Universitat De Les Illes Balears | Utilizacion de fitato como agente inhibidor de la disolucion de cristales de sales calcicas para la prevencion o tratamiento de la osteoporosis. |
| EP2152085A4 (en) * | 2007-05-01 | 2012-05-23 | Normoxys Inc | COMPLEMENTATION OR REPLACEMENT OF ERYTHROPOIETIN |
| ES2332636B1 (es) * | 2008-08-06 | 2011-02-10 | Universitat De Les Illes Balears | Composicion de liquido de dialisis. |
| US9364490B2 (en) | 2013-03-15 | 2016-06-14 | Laboratoris Sanifit, S.L. | Use of derivatives containing C—O—P bonds in patients with kidney failure |
| ES2495666B1 (es) * | 2013-03-15 | 2015-08-10 | Laboratoris Sanifit, S.L. | Uso de derivados con enlaces c-o-p en pacientes con fallo renal |
| DE102016013737A1 (de) | 2016-11-17 | 2018-05-17 | WindplusSonne GmbH | Hexahydroxycyclohexanhexaphosphorsäureestersalze zur Behandlung von Kalzinose sowie diätische Lebensmittel mit Hexahydroxycyclohexanhexaphosphorsäureestersalzen als Zusatzstoffe |
| JPWO2019176693A1 (ja) * | 2018-03-15 | 2021-02-25 | 国立大学法人広島大学 | 骨外組織における骨形成関連因子又は石灰化関連因子の発現抑制剤 |
| KR20240110085A (ko) | 2018-10-11 | 2024-07-12 | 사니핏 테라퓨틱스 에스.에이. | 이소성 석회화의 치료를 위한 이노시톨 포스페이트 |
| KR20210148078A (ko) | 2019-01-30 | 2021-12-07 | 사니핏 테라퓨틱스 에스.에이. | 조직 관류 증가에 사용하기 위한 이노시톨 포스페이트 화합물 |
| EP3818983A1 (en) | 2019-11-11 | 2021-05-12 | Sanifit Therapeutics S.A. | Inositol phosphate compounds for use in treating, inhibiting the progression, or preventing cardiovascular calcification |
| EP4015494A1 (en) | 2020-12-15 | 2022-06-22 | Sanifit Therapeutics S.A. | Processes for the preparation of soluble salts of inositol phosphates |
| EP4036097A1 (en) | 2021-01-29 | 2022-08-03 | Sanifit Therapeutics S.A. | Ip4-4,6 substituted derivative compounds |
| TW202412815A (zh) | 2022-07-29 | 2024-04-01 | 西班牙商薩尼菲特治療公司 | Ip5經取代化合物 |
| WO2024023359A1 (en) | 2022-07-29 | 2024-02-01 | Sanifit Therapeutics, S.A. | Ip4-4,6 substituted derivative compounds for use in the treatment, inhibition of progression, and prevention of ectopic calcification |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3934002A (en) * | 1972-06-30 | 1976-01-20 | The Procter & Gamble Company | Oral compositions for plaque, caries and calculus retardation with reduced staining tendencies |
| JPH01305033A (ja) * | 1988-06-01 | 1989-12-08 | Sanwa Kagaku Kenkyusho Co Ltd | 循環改善剤及び循環改善機能性食品並びにし好品 |
| US5082833A (en) * | 1988-06-30 | 1992-01-21 | Shamsuddin Abulkalam M | Reduction of cell proliferation and enhancement of nk-cell activity |
| US5268176A (en) * | 1991-07-22 | 1993-12-07 | Avon Products, Inc. | Method and compositions for the non-invasive treatment of telangiectasia |
| US5516801A (en) * | 1992-08-21 | 1996-05-14 | Scotia Holdings Plc | Fatty acid treatment for ectopic calcium deposition |
| DE4444238A1 (de) * | 1994-12-13 | 1996-06-20 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden |
| US6359194B1 (en) * | 1995-02-10 | 2002-03-19 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| US5536499A (en) * | 1995-02-24 | 1996-07-16 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Cosmetic compositions for reducing or preventing signs of cellulite |
| US5821237A (en) * | 1995-06-07 | 1998-10-13 | The Procter & Gamble Company | Compositions for visually improving skin |
| US5614511A (en) * | 1996-03-11 | 1997-03-25 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Cosmetic compositions for treating itchy skin |
| JP3623430B2 (ja) * | 2000-07-06 | 2005-02-23 | 築野ライスファインケミカルズ株式会社 | 抗酸化性組成物 |
| JP2003238414A (ja) * | 2001-12-13 | 2003-08-27 | Sangaku Renkei Kiko Kyushu:Kk | 医薬組成物 |
| EP1327443A1 (en) * | 2001-12-21 | 2003-07-16 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic or preventing agent for the diseases caused by a decrease in the expression level of the klotho protein |
-
2003
- 2003-11-07 ES ES200302600A patent/ES2232302B1/es not_active Expired - Fee Related
-
2004
- 2004-11-03 JP JP2006538978A patent/JP4786543B2/ja not_active Expired - Fee Related
- 2004-11-03 DK DK04798764T patent/DK1680128T3/da active
- 2004-11-03 DE DE602004004817T patent/DE602004004817T2/de active Active
- 2004-11-03 AT AT04798764T patent/ATE353655T1/de active
- 2004-11-03 ES ES04798764T patent/ES2282920T3/es active Active
- 2004-11-03 SI SI200430274T patent/SI1680128T1/sl unknown
- 2004-11-03 MX MXPA06005043A patent/MXPA06005043A/es active IP Right Grant
- 2004-11-03 EP EP04798764A patent/EP1680128B1/en active Active
- 2004-11-03 US US10/595,709 patent/US20070066574A1/en not_active Abandoned
- 2004-11-03 WO PCT/IB2004/003588 patent/WO2005044278A1/en active IP Right Grant
- 2004-11-03 CA CA2544963A patent/CA2544963C/en not_active Expired - Fee Related
- 2004-11-03 PL PL04798764T patent/PL1680128T3/pl unknown
- 2004-11-03 BR BRPI0415713-3A patent/BRPI0415713A/pt not_active IP Right Cessation
- 2004-11-03 PT PT04798764T patent/PT1680128E/pt unknown
-
2007
- 2007-05-10 CY CY20071100626T patent/CY1106574T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1106574T1 (el) | 2012-01-25 |
| CA2544963C (en) | 2010-03-30 |
| DE602004004817D1 (de) | 2007-03-29 |
| JP2007510710A (ja) | 2007-04-26 |
| JP4786543B2 (ja) | 2011-10-05 |
| SI1680128T1 (sl) | 2007-08-31 |
| PT1680128E (pt) | 2007-05-31 |
| US20070066574A1 (en) | 2007-03-22 |
| BRPI0415713A (pt) | 2006-12-19 |
| ES2282920T3 (es) | 2007-10-16 |
| EP1680128B1 (en) | 2007-02-14 |
| PL1680128T3 (pl) | 2007-07-31 |
| DE602004004817T2 (de) | 2007-11-22 |
| ES2232302A1 (es) | 2005-05-16 |
| WO2005044278A1 (en) | 2005-05-19 |
| MXPA06005043A (es) | 2007-03-15 |
| ATE353655T1 (de) | 2007-03-15 |
| EP1680128A1 (en) | 2006-07-19 |
| CA2544963A1 (en) | 2005-05-19 |
| ES2232302B1 (es) | 2006-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1680128T3 (da) | Myo-inositolhexaphosphat til topisk anvendelse | |
| MXPA05011208A (es) | Uso de ivermectina para el tratamiento de desordenes dermatologicos. | |
| NO20064186L (no) | Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod | |
| AR047841A1 (es) | Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios | |
| CR9949A (es) | Inhibidores de proteina activadora de la 5-lipoxigenasa (flap) | |
| ATE355065T1 (de) | Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika | |
| NO20064041L (no) | Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter | |
| ATE534378T1 (de) | Titrierung von tapentadol | |
| WO2009002867A3 (en) | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement | |
| AR109263A2 (es) | Composición que comprende moxidectina | |
| BRPI0509053A (pt) | composição farmacêutica anidra e uso de um agente siliconado e de uma composição | |
| DE602006009259D1 (de) | Pharmazeutische zusammensetzung mit einem organopoirkstoff | |
| EA200702336A1 (ru) | ПРИМЕНЕНИЕ 24-норУДХК | |
| ECSP077843A (es) | Tratamiento o prevención del prurito | |
| EA200970353A1 (ru) | Комбинированное лекарственное средство | |
| BRPI0611526A2 (pt) | composição tópica contendo gelatina | |
| DE602005010844D1 (de) | Pharmazeutische zusammensetzungen mit interferon-tau | |
| BRPI0512316A (pt) | métodos para prevenir ou atenuar uma ou mais complicações da hemorragia intracerebral e para prevenir ou atenuar uma ou mais complicações da ich em uma maioria de pacientes com ich, e, uso de um primeiro agente de coagulação | |
| PT1220676E (pt) | Prevencao do cancro colorrectal | |
| EA200801890A1 (ru) | Средство для лечения шума в ушах | |
| DK1675611T3 (da) | Terapeutiske anvendelser for C-peptid | |
| CR8584A (es) | Piperazinas derivadas de urea para el tratamiento de la endometrosis | |
| ATE484288T1 (de) | Pharmazeutische zusammensetzungen zur linderung von übermässig hohen zuckerspiegeln bei diabetikern | |
| ATE357220T1 (de) | Pharmazeutische zusammensetzung mit modifizierter freisetzung | |
| BRPI0510503A (pt) | compostos e composições como inibidores de catepsina s |